Primary hyperparathyroidism is a condition in which one or more of your parathyroid glands produce too much parathyroid hormone (PTH), driving blood calcium levels above normal. It is the most common cause of elevated calcium found on routine blood tests and, in the vast majority of cases, stems from a noncancerous growth on a single parathyroid gland. The condition can quietly damage bones and kidneys for years before causing obvious symptoms, but it is also one of the most curable endocrine disorders once identified.
What the Parathyroid Glands Actually Do
Most people have four parathyroid glands, each roughly the size of a grain of rice, tucked behind the thyroid in the neck. Despite the similar name, they have nothing to do with thyroid function. Their sole job is to keep blood calcium in a narrow range by releasing PTH. When calcium dips, PTH tells your bones to release stored calcium, signals the kidneys to hold on to calcium instead of filtering it out, and boosts the activation of vitamin D so your gut absorbs more calcium from food. This feedback loop works well when the glands respond normally to rising and falling calcium levels.
In primary hyperparathyroidism, one or more glands stop obeying that feedback. They keep pumping out PTH even when blood calcium is already high. The result is a slow, steady surplus of calcium in the bloodstream, with downstream effects on nearly every organ system.
What Causes It
The overwhelming majority of cases trace to a single benign tumor called a parathyroid adenoma, responsible for roughly 80 to 85 percent of diagnoses. Another 10 to 15 percent involve hyperplasia, where all four glands enlarge and overproduce hormone. Parathyroid cancer accounts for less than 1 percent of cases.1PubMed Central. Parathyroid adenoma No one knows exactly why a sporadic adenoma forms in most people, though prior radiation to the head or neck and longstanding vitamin D deficiency have been flagged as contributing factors.
A small but clinically important fraction of cases are hereditary. The best known inherited form occurs in multiple endocrine neoplasia type 1 (MEN1), caused by a mutation in the gene encoding a tumor-suppressor protein called menin.2PubMed Central. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery? But MEN1 is not the only genetic culprit. Hereditary primary hyperparathyroidism can also appear in MEN types 2 through 5, in hyperparathyroidism-jaw tumor syndrome, and in several non-syndromic familial forms.3PubMed Central. Genetics of hereditary forms of primary hyperparathyroidism Genetic testing matters in these families because management often differs: MEN1 patients, for instance, tend to have multigland disease requiring broader surgery and longer surveillance.
How It Affects the Skeleton
Bones are the body’s main calcium warehouse, and chronic PTH excess steadily draws down that supply. A hallmark pattern is bone mineral density loss at cortical sites, like the forearm and hip, while the spine’s trabecular bone may look relatively preserved on a standard density scan.4PubMed. Bone health evaluation in primary hyperparathyroidism using dual-energy X-ray absorptiometry and trabecular bone score That pattern can be misleading. Even when bone density numbers seem adequate, the microarchitecture of bone deteriorates, and fracture risk goes up at both cortical and trabecular sites. A newer measurement called the trabecular bone score, which estimates bone quality from a standard spine scan, tends to be lower in people with primary hyperparathyroidism, capturing some of that hidden fragility.4PubMed. Bone health evaluation in primary hyperparathyroidism using dual-energy X-ray absorptiometry and trabecular bone score
The practical takeaway: if you have been told your bone density is “not that bad” but you have confirmed primary hyperparathyroidism, the standard density reading may be underestimating your fracture risk.
Kidney Stones and Kidney Damage
Kidney stones are the other classic complication. Excess calcium floods the urine, and when concentrations get high enough, calcium-based stones form. The presence of a kidney stone, whether or not it causes symptoms, is enough to classify the disease as symptomatic and push it toward surgical treatment.5PubMed Central. Renal manifestations of primary hyperparathyroidism Stone-forming patients tend to have higher bone turnover, higher urinary calcium, and more aggressive disease overall.6PubMed Central. Timely Evaluation and Management of Primary Hyperparathyroidism in Patients with Kidney Stones
Beyond stones, the disease can also lead to nephrocalcinosis (calcium deposits within kidney tissue) and a gradual decline in kidney function. Nephrocalcinosis is largely reversible after successful surgery, though some residual risk persists.5PubMed Central. Renal manifestations of primary hyperparathyroidism
Neuropsychiatric and Cardiovascular Effects
Many people with primary hyperparathyroidism describe feeling “off” in ways that do not obviously point to a calcium problem. About a quarter of patients experience neuropsychiatric symptoms, ranging from fatigue, depression, and anxiety to cognitive fog.7PubMed Central. Neuropsychiatric manifestations of primary hyperparathyroidism In rarer cases, elevated calcium can trigger mania, delirium, or psychosis. The underlying mechanism is likely a combination of direct effects on brain chemistry from both high PTH and high calcium, including interference with neurotransmitter signaling and increased neuroinflammation.7PubMed Central. Neuropsychiatric manifestations of primary hyperparathyroidism
Cardiovascular risk is another area that has been debated for decades. In severe or longstanding disease, the link to higher cardiovascular illness and death is well established. Whether mild disease carries the same risk is less clear, though there is evidence of subtler changes like increased stiffness in blood vessel walls.8PubMed Central. Nontraditional manifestations of primary hyperparathyroidism This uncertainty is one reason doctors sometimes debate how aggressively to treat mild cases.
Diagnosis and the FHH Lookalike
The diagnosis itself is straightforward when classic: high blood calcium paired with a PTH level that is elevated or “inappropriately normal” (meaning the body should have suppressed it in response to the high calcium). Routine blood work often catches it incidentally. Where things get tricky is distinguishing primary hyperparathyroidism from a genetic condition called familial hypocalciuric hypercalcemia (FHH). FHH produces a nearly identical lab picture: mildly elevated calcium with PTH that has not shut off.9PubMed. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism
The distinction matters enormously because FHH is generally harmless, requires no treatment, and surgery does not fix it.10PubMed Central. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up Performing a parathyroidectomy on someone who actually has FHH means putting them through a needless operation. The initial screening test is a urine calcium-to-creatinine clearance ratio: a very low value points toward FHH.11The Journal of Clinical Endocrinology & Metabolism. Distinguishing Typical Primary Hyperparathyroidism From Familial Hypocalciuric Hypercalcemia by Using an Index of Urinary Calcium However, there is a gray zone where the two overlap, and genetic testing for mutations in the calcium-sensing receptor gene is the definitive way to settle it.9PubMed. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism
Normocalcemic Primary Hyperparathyroidism
There is also a subtler variant that can confuse both patients and clinicians. In normocalcemic primary hyperparathyroidism, PTH is consistently elevated on at least two measurements over several months, yet serum calcium stays within the normal range.12Journal of Bone and Mineral Research. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop – Section: Clinical presentations of PHPT You might think normal calcium means normal consequences, but that is not always the case. In one characterization of this group, more than half had osteoporosis and about 14 percent had a history of kidney stones.13The Journal of Clinical Endocrinology & Metabolism. Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype Over time, roughly 40 percent of these patients went on to develop clear-cut complications, including rising calcium, new stones, fractures, or significant bone loss.13The Journal of Clinical Endocrinology & Metabolism. Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype This form may represent the earliest stage of the disease, caught before calcium has had time to climb.
How Surgeons Find the Culprit Gland
Once surgery is on the table, the next step is figuring out which gland is the problem. Surgeons rely on imaging studies before the operation, most commonly neck ultrasound and a nuclear medicine scan called sestamibi SPECT/CT. Neither is perfect on its own. In one study of over a thousand patients, ultrasound failed to detect any gland in about 23 percent of cases, and sestamibi missed about 28 percent.14PubMed. Accuracy of Parathyroid Adenoma Localization by Preoperative Ultrasound and Sestamibi in 1089 Patients with Primary Hyperparathyroidism Combining the two improves results considerably. A smaller study found that when both scans agreed, the combined sensitivity reached about 95 percent.15PubMed. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism
A newer option, four-dimensional CT (4D CT), is gaining ground, particularly for small or hard-to-find adenomas. In a recent comparison, 4D CT achieved a sensitivity of about 88 percent overall and detected 100 percent of adenomas smaller than 20 millimeters, outperforming both ultrasound and sestamibi for those smaller growths.16PubMed Central. Diagnostic Accuracy of 4D CT in Detecting Parathyroid Adenoma Compared With Ultrasound and Sestamibi SPECT/CT in Primary Hyperparathyroidism: A Retrospective Study Not every center offers 4D CT yet, but it is increasingly used when initial imaging is inconclusive.
When Surgery Is Recommended
Surgery to remove the overactive parathyroid tissue, known as parathyroidectomy, is the only cure. Current guidelines recommend it for anyone whose serum calcium is more than 1 mg/dL above the upper limit of normal, regardless of symptoms.17JAMA Surgery. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism – Section: Indications and Outcomes of Intervention Surgery is also indicated for people who have kidney stones, significant bone loss, reduced kidney function, or are younger than 50. The Fourth International Workshop guidelines expanded the evaluation to look more carefully at both the skeleton and kidneys, and skeletal or renal involvement found on further testing now counts as a reason to operate.18PubMed Central. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop
People who do not meet surgical criteria are monitored with periodic calcium, PTH, bone density, and kidney function checks. For many of them, the disease stays stable for years. But some do eventually cross a threshold, so ongoing surveillance is important.
What the Operation Looks Like
Parathyroid surgery has changed dramatically over the past two decades. The traditional approach involved exploring both sides of the neck and examining all four glands. Today, when imaging clearly identifies a single adenoma, most experienced surgeons perform a focused (minimally invasive) operation through a small incision, targeting just the abnormal gland.19PubMed Central. Intraoperative Parathyroid Hormone Monitoring in the Surgical Management of Sporadic Primary Hyperparathyroidism
A key tool during the procedure is real-time monitoring of PTH levels. Blood is drawn before and after the suspected gland is removed, and if PTH drops by at least 50 percent within minutes, the surgeon can be confident that all overactive tissue has been taken out.20JAMA Surgery. An Optimal Algorithm for Intraoperative Parathyroid Hormone Monitoring If the drop is insufficient, it signals the possibility of a second abnormal gland, prompting further exploration during the same operation. This monitoring has pushed cure rates above 97 percent in some series, compared to about 93 percent without it.21PubMed. Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring The focused approach with monitoring is typically performed as a same-day or short-stay procedure, and most people return to normal activity within a week or two.
One complication worth knowing about is hungry bone syndrome, which can develop after surgery in patients whose bones have been especially depleted. Once PTH drops, bone rapidly begins reclaiming calcium from the blood, leading to a sudden, sometimes severe drop in blood calcium, along with low phosphorus and low magnesium.22Endocrinología, Diabetes y Nutrición (English ed.). Risk factors and evolution of calcium and parathyroid hormone levels in hungry bone syndrome after parthyroidectomy for primary hyperparathyroidism Patients at higher risk for this are those with markedly elevated PTH or very high bone turnover before surgery. It is managed with aggressive calcium and vitamin D supplementation and usually resolves over days to weeks.
Medical Alternatives When Surgery Is Not an Option
Some people cannot undergo surgery because of other health conditions, personal choice, or mild disease that does not yet meet operative criteria. For them, a medication called cinacalcet offers a nonsurgical way to control blood calcium. Cinacalcet works by making the calcium-sensing receptor on parathyroid cells more sensitive, so the glands dial back PTH secretion in response to lower calcium concentrations.23PubMed. The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies
The drug is effective at lowering calcium. In pooled data from randomized trials, cinacalcet was far more likely than placebo to bring calcium back to normal within several months.23PubMed. The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies A meta-analysis found that roughly 90 percent of patients on cinacalcet achieved normal calcium levels.24PubMed Central. Cinacalcet and primary hyperparathyroidism: systematic review and meta regression PTH levels also decrease, and some patients report improved cognition.25PubMed Central. Cinacalcet treatment of primary hyperparathyroidism The catch is that cinacalcet does not address bone loss. For bone protection, drugs like alendronate or denosumab can be added to increase bone density.26Journal of Bone and Mineral Research. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop – Section: Medical/Management of PHPT Medical therapy manages the consequences but does not cure the disease, so regular follow-up remains essential.
Vitamin D and Primary Hyperparathyroidism
Many patients with primary hyperparathyroidism also have low vitamin D, and the two problems interact in a way that can confuse treatment decisions. Low vitamin D drives PTH even higher, worsening the hormonal imbalance, and is associated with a greater risk of hungry bone syndrome after surgery.27PubMed. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial Historically, doctors worried that giving vitamin D to someone with primary hyperparathyroidism could push calcium dangerously high. Randomized trial data have largely eased that concern: careful supplementation to bring vitamin D into a reasonable range is now considered safe in most patients and may actually help lower PTH levels before surgery.27PubMed. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial Still, it should be done under monitoring, since individual responses vary.
Quality of Life After Surgery
One of the most encouraging aspects of treatment is how much better people feel once the overactive gland is removed. In a prospective study tracking patients for 12 months after surgery, quality of life improved across the board, and the improvement held for people with both mild and more severe hypercalcemia.28PubMed. Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study Many patients describe a lifting of brain fog, better energy, and improved mood that they did not fully appreciate was abnormal until it resolved. This is worth noting because patients with mild disease sometimes wonder whether surgery is worth it. The quality-of-life data suggest that even people with modestly elevated calcium can experience meaningful symptom relief.
Primary Hyperparathyroidism in Pregnancy
The disease creates particular challenges during pregnancy because elevated calcium crosses the placenta and affects the developing baby. Untreated maternal hypercalcemia raises the risk of problems including restricted fetal growth, neonatal low calcium, and stillbirth. It can also worsen kidney stones and kidney function in the mother.29PubMed Central. Primary Hyperparathyroidism in Pregnancy: Parathyroidectomy in the Third Trimester When surgery is needed, the second trimester is the preferred window, since the risk of miscarriage has dropped and the uterus is not yet large enough to significantly increase the risk of preterm labor. Third-trimester surgery is generally avoided but has been performed successfully when the dangers of leaving the calcium uncorrected outweigh the operative risks.29PubMed Central. Primary Hyperparathyroidism in Pregnancy: Parathyroidectomy in the Third Trimester
When It Happens in Adolescents
Primary hyperparathyroidism in teenagers and children is rare but distinct enough from the adult disease that some researchers consider it a separate entity. Adolescents tend to present with more symptoms, and the disease is more frequently driven by an underlying genetic cause, whether or not there is a known family history.30PubMed. Adolescent primary hyperparathyroidism Young patients may show features rarely seen in adults, including rickets-like bone changes, and the overall severity of clinical findings tends to be greater.31PubMed. Variable presentation and outcomes of primary hyperparathyroidism in children and adolescents Genetic testing is especially valuable in this age group because it influences not only the surgical approach but also what other endocrine tumors to screen for over a lifetime.